Clinical Trial Update: Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lonafarnib, ritonavir, and lambda interferon for chronic hepatitis D has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D
• Liver Disease

Drugs mentioned

• Lambda interferon (lambda interferon)
• Lonafarnib (lonafarnib)
• Ritonavir (Ritonavir)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Liver Disease, Hepatitis D | Phase 2 | Status: COMPLETED | Results posted: 2021-12-01